[Immunization in France: high quality regulation].
作者信息
Fuchs F
机构信息
Agence française de sécurité sanitaire des produits de santé (Afssaps), direction des laboratoires et des contrôles, France.
出版信息
Arch Pediatr. 2006 Jun;13(6):648-50. doi: 10.1016/j.arcped.2006.03.121. Epub 2006 May 12.
PMID:16697585
Abstract
摘要
相似文献
1
[Immunization in France: high quality regulation].[法国的免疫接种：高质量监管]
Arch Pediatr. 2006 Jun;13(6):648-50. doi: 10.1016/j.arcped.2006.03.121. Epub 2006 May 12.
2
[Immunization: adverse event reporting system].
Arch Pediatr. 2006 Jun;13(6):646-8. doi: 10.1016/j.arcped.2006.03.125. Epub 2006 May 12.
3
Risk management ... National Childhood Vaccine Injury Act of 1986.风险管理……1986年《国家儿童疫苗伤害法案》
Trends Health Care Law Ethics. 1992 Winter;7(2):41-4.
4
[Vaccines' adverse events: questions and answers brought by InfoVac].[疫苗不良事件：InfoVac带来的问答]
Arch Pediatr. 2006 Jun;13(6):650-2. doi: 10.1016/j.arcped.2006.03.043. Epub 2006 May 11.
5
Standards for child and adolescent immunization practices. National Vaccine Advisory Committee.儿童和青少年免疫接种实践标准。国家疫苗咨询委员会。
Pediatrics. 2003 Oct;112(4):958-63.
6
The development of standardized case definitions and guidelines for adverse events following immunization.免疫接种后不良事件标准化病例定义和指南的制定。
Vaccine. 2007 Aug 1;25(31):5671-4. doi: 10.1016/j.vaccine.2007.02.063. Epub 2007 Mar 12.
7
[Safe drugs for children].[儿童安全用药]
Krankenpfl J. 2004;42(7-10):230.
8
The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.制药行业在发展中国家传播药物警戒实践中的作用。
Food Drug Law J. 2008;63(3):701-11.
9
[Network for investigation of medicinal products in children].[儿童药品研究网络]
Arch Pediatr. 2006 Jun;13(6):631-4. doi: 10.1016/j.arcped.2006.03.092. Epub 2006 May 12.
10
The role of editorial peer review in the evaluation of vaccine safety.
Vaccine. 2004 May 7;22(15-16):2073-5. doi: 10.1016/j.vaccine.2004.01.012.
Zotero 插件